EUROGENE LIMITED has a total of 14 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United Kingdom and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and foods and drinks are NAOMI BALABAN, MACROCURE LTD and TISSUETECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 5 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Foods and drinks | |
#4 | Biotechnology | |
#5 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Enzymes | |
#4 | Object sterilising | |
#5 | Microorganisms | |
#6 | Implantable devices | |
#7 | Special macromolecular compounds | |
#8 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Barker Stephen George Edward | 3 |
#2 | Martin John Francis | 3 |
#3 | Ylae-Herttuala Seppo | 2 |
#4 | Lehtolainen Pauliina | 1 |
#5 | Erusalimsky Jorge Daniel | 1 |
#6 | Yla-Herttuala Seppo | 1 |
#7 | Marjomaki Varpu | 1 |
#8 | Montgomery Hugh Edward | 1 |
#9 | Airenne Kari | 1 |
#10 | Kulomaa Markku | 1 |
Publication | Filing date | Title |
---|---|---|
GB0018148D0 | Peptides and their use | |
GB0015016D0 | Biotin-binding materials | |
GB0012997D0 | Gene delivery | |
GB0012250D0 | The treatment of intimal hyperplasia, and materials for use therein | |
GB9911566D0 | The treatment of intimal hyperplasia and materials for the use therein | |
GB9909067D0 | Combination therapy | |
GB9813653D0 | Fusion proteins | |
GB9809082D0 | Delivery device |